The downgrade from Buy to Neutral by a reputable analyst firm, coupled with a significant reduction in the price target, is likely to negatively impact investor sentiment and the short-term stock price of Asensus Surgical. Such a drastic change in both rating and price target suggests a less favorable outlook on the company's future performance or market conditions, leading to potential selling pressure.